Hysteroscopic Lymphatic Mapping for Endometrial Cancer
NCT00671606 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 5
Last updated 2016-05-27
Summary
The goal of this clinical research study is to learn if a procedure called intraoperative (during surgery) lymphatic mapping can be used to find the sentinel lymph node in patients with endometrial cancer.
Conditions
Interventions
- PROCEDURE
-
Intraoperative Lymphatic Mapping
Intraoperative hysteroscopic injection of patent blue dye and radiocolloid for detection of sentinel lymph nodes.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Michael M. Frumovitz, MD · M.D. Anderson Cancer Center
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Harnessing the Disease Signatures From Endometrium and Menstrual Blood to Identify Avenues for the Treatment of Chronic Conditions Such as Endometriosis and Related Pathologies: This is an Observational Study Aimed at Shedding Light on Women's Health
NCT06990971 ·Status: NOT_YET_RECRUITING
-
Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance
NCT03756480 ·Status: ACTIVE_NOT_RECRUITING
-
Predicting Endometrial Receptivity for Optimal Reproductive Management
NCT04107129 ·Status: COMPLETED
-
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
NCT01301885 ·Status: RECRUITING
-
Efficacy of Cryoablation of Abdominal Wall Endometriosis
NCT03627676 ·Status: UNKNOWN ·Phase: NA
-
Endometrial Cancer Lymphadenectomy Trial
NCT03438474 ·Status: RECRUITING ·Phase: NA
-
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
NCT04586959 ·Status: RECRUITING ·Phase: NA
-
Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr
NCT06799624 ·Status: NOT_YET_RECRUITING
-
Ultrasound and Endometrial Hyperplasia
NCT00123188 ·Status: TERMINATED ·Phase: NA
-
The Role of Endometrial Blood Flow in Endometrial Cancer
NCT05034991 ·Status: RECRUITING
-
Medroxyprogesterone Acetate With or Without Entinostat Before Surgery in Treating Patients With Endometrioid Endometrial Cancer
NCT03018249 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Proof of Concept Study to Eval MetriDx Lab-developed Test to Identify Endometriosis-specific Bio Markers
NCT05698212 ·Status: UNKNOWN ·Phase: PHASE2
-
Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer
NCT05945407 ·Status: RECRUITING ·Phase: NA
-
Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients
NCT06148129 ·Status: COMPLETED ·Phase: NA
-
Artificial inTelligence in eNdometriosis-related ovArian Cancer and Precision Surgery in eNdometriosis-related ovArian Cancer
NCT05161949 ·Status: UNKNOWN
-
AD-SVF Therapy for Refractory Endometrial Infertility
NCT07230600 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy
NCT02335203 ·Status: UNKNOWN ·Phase: PHASE2
-
Medroxyprogesterone Acetate vs LNG-IUS in Early-stage Endometrioid Carcinoma and Atypical Hyperplasia Patients
NCT05565573 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus
NCT00064025 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer
NCT00003179 ·Status: TERMINATED ·Phase: PHASE2
-
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
NCT01468935 ·Status: COMPLETED
-
Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis
NCT02975219 ·Status: UNKNOWN ·Phase: PHASE1
-
Endometriosis Biomarker Discovery Study
NCT03272360 ·Status: WITHDRAWN
-
Percutaneous Imaging-guided Cryoblation of the Anterior Abdominal Wall Endometriosis Scars
NCT06108167 ·Status: UNKNOWN
-
Programmed Death-1(PD-1) Inhibitor Combined With Progesterone Treatment in Endometrial Cancer
NCT04046185 ·Status: UNKNOWN ·Phase: EARLY_PHASE1